The good thing about rituximab is that it has a therapeutic role, indications such as diffuse large B-cell lymphoma, follicular non-Hodgkin’s lymphoma, maintenance treatment of inert B-cell lymphoma, etc., and the bad thing is that there are adverse reactions to rituximab such as fever, chills, nausea, headache and rash.
1.The good thing about rituximab: there are therapeutic indications including: combination with CHOP regimen for the treatment of CD20-positive diffuse large B-cell lymphoma, and combination with chemotherapeutic agents for the treatment of CD20-positive stage III IV follicular non-Hodgkin’s lymphoma. Maintenance therapy for inert B-cell lymphoma, etc. Relapsed or drug-resistant inert B-cell lymphoma.
2. Rituximab bad: there are adverse reactions such as fever, chills, nausea and headache and rash, hypotension and bronchospasm. Rituximab is contraindicated for those who are allergic to rituximab.
The application of rituximab is recommended under the guidance of a doctor, and it is recommended to go to the hospital for a clear diagnosis and treatment.